Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Leases (2019 - 2026)

Usana Health Sciences has reported Leases over the past 6 years, most recently at $23.0 million for Q1 2026.

  • Quarterly Leases rose 8.39% to $23.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Jan 2026, up 8.39% year-over-year, with the annual reading at $23.0 million for FY2026, 8.39% up from the prior year.
  • Leases was $23.0 million for Q1 2026 at Usana Health Sciences, up from $21.2 million in the prior quarter.
  • Over five years, Leases peaked at $23.8 million in Q1 2022 and troughed at $17.7 million in Q4 2023.
  • The 4-year median for Leases is $21.2 million (2024), against an average of $21.1 million.
  • Year-over-year, Leases fell 15.94% in 2022 and then rose 19.84% in 2024.
  • A 4-year view of Leases shows it stood at $20.0 million in 2022, then decreased by 11.63% to $17.7 million in 2023, then rose by 19.84% to $21.2 million in 2024, then increased by 8.39% to $23.0 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Leases are $23.0 million (Q1 2026), $21.2 million (Q4 2024), and $17.7 million (Q4 2023).